Stefaan Rossenu

Antithrombotic drug candidate ALX-0081 shows superior preclinical efficacy and safety compared with currently marketed antiplatelet drugs

Hans Ulrichts, Karen Silence, Anne Schoolmeester et al. · Blood · 2011 · 181 citations · Full text

Medicine, Pharmacology, Clinical Pharmacology +7

Evaluation of efficacy and safety of the anti-VWF Nanobody ALX-0681 in a preclinical baboon model of acquired thrombotic thrombocytopenic purpura

Filip Callewaert, Jan Roodt, Hans Ulrichts et al. · Blood · 2012 · 141 citations

Medicine, Hematology, Pharmacology +6

Using Model-Based “Learn and Confirm” to Reveal the Pharmacokinetics-Pharmacodynamics Relationship of Pembrolizumab in the KEYNOTE-001 Trial

Jeroen Elassaiss‐Schaap, Stefaan Rossenu, Andreas Lindauer et al. · CPT Pharmacometrics & Systems Pharmacology · 2016 · 116 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Population Pharmacokinetics of Esketamine Nasal Spray and its Metabolite Noresketamine in Healthy Subjects and Patients with Treatment-Resistant Depression

Carlos Pérez‐Ruixo, Stefaan Rossenu, Peter Zannikos et al. · Clinical Pharmacokinetics · 2020 · 76 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

The effect of macrophage and angiogenesis inhibition on the drug release and absorption from an intramuscular sustained-release paliperidone palmitate suspension

Nicolas Darville, Marjolein van Heerden, Dirk Mariën et al. · Journal of Controlled Release · 2016 · 67 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +16